variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
CBS-I278T,CBS,This recessive mutation causes homocystinuria in a recessive manner and is found in patients responsive to pyridoxine treatment.,High,Likely,Pathogenic,0.0029,Genital and urinary;Metabolism,Recessive,Heterozygous,7611293;8554066;8940271;9813456;15972722;19683694,rs5742905,5,chr21,44483184,G,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
SIAE-M89V,SIAE,"This variant was reported to be associated with autoimmune disease when homozygous. However, a later publication has contradicted this result, finding no significant association between this variant and autoimmune disease in a very large cohort.",Moderate,Uncertain,Pathogenic,0.04,Immune system,Recessive,Heterozygous,20555325;22200769,rs78778622,3,chr11,124530664,C,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
COL4A1-Q1334H,COL4A1,"This common variant has been associated with arterial stiffness and, in Japanese, a small increased risk of myocardial infarction (MI, a.k.a. heart attack). This last observation supported a dominant effect for this variant and, assuming a lifetime risk of 15% for MI, we estimate carriers have an additional risk of 0.5-3%.",Low,Likely,Pathogenic,0.32,Heart and circulatory,Dominant,Heterozygous,10334796;18077766;20031579,rs3742207,2,chr13,110818598,G,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
MTRR-I49M,MTRR,"This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as ""MTRR I22M"" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.",Low,Likely,Pathogenic,0.45,Anatomical and congenital;Metabolism;Nervous system,Recessive,Homozygous,10444342;10930360;11807890;12375236;15060097;15979034;17024475,rs1801394,1,chr5,7870973,G,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
PRF1-A91V,PRF1,"This variant may be associated with a slightly increased susceptibility to some rare blood disorders, in particular autoimmune proliferative disease, if combined with a more severe mutation elsewhere. Most reports lack statistical significance.",Low,Likely,Pathogenic,0.033,Blood;Immune system,Complex/Other,Heterozygous,16720836;17311987;17475905,rs35947132,1,chr10,72360387,A,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
AMPD1-Q12X,AMPD1,"Causes Adenosine Deaminase Deficiency in a recessive manner. Most of the time individuals do not report symptoms, but when symptoms do exist they to be post-exercise symptoms of muscle weakness, muscle pain, and getting tired more quickly.",Low,Likely,Pathogenic,0.093,"Metabolism;Muscular, skeletal, and connective tissue",Recessive,Heterozygous,1631143,rs17602729,4,chr1,115236057,A,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
MBL2-G54D,MBL2,"This variant is associated with mannose binding protein deficiency which leads to impaired complement system immune response to mannose-rich pathogens. Patients homozygous for this allele or compound heterozygous are likely to have increased susceptibility to infection, but Hellemann et al. report heterosis for intensive care outcomes in heterozygous subjects. The wild-type version of this gene is known as variant allele A, while this is called variant allele B. See R52C (variant D) and G57E (variant C).",Low,Likely,Pathogenic,0.1,Immune system,Recessive,Heterozygous,7564730;10199352;17872904,rs1800450,3,chr10,54531235,T,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
rs5186,,"This common noncoding genetic variant has an allele frequency of ~30% and is associated with an increased risk of hypertension. If ~25% of non-carriers have hypertension, Bonnardeaux et al's data predict ~4% increased risk of hypertension per copy of this variant. This SNP is in the 3' noncoding region of the AGTR1 transcript (angiotensin II type 1 receptor), also known as AT2R1 or AT1R, which is a target of hypertension drugs.",Low,Likely,Pathogenic,0.21,Drug response;Heart and circulatory,Unknown,Homozygous,"8021009;
11250978;11593098;16046653;16675453;17668390",rs5186,2,chr3,148459988,C,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
RNASEL-R462Q,RNASEL,"Associated with increased risk of prostate cancer in individuals who already have a family history of prostate cancer, but studies have been unable to replicate this finding in sporadic (non-familial) prostate cancer cases.",Low,Uncertain,Pathogenic,0.28,Cancer;Genital and urinary,Complex/Other,Heterozygous,11941539;12022038;12415269;17407163,rs486907,2,chr1,182554557,T,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
ELAC2-S217L,ELAC2,"Reported to be associated with increased susceptibility to prostate cancer, but later studies weaken the hypothesis. Xu et al.'s meta-analysis concludes that there is a small but significant increased risk (OR = 1.13). Assuming a lifetime risk of 16% for prostate cancer we calculate this leads to an increased risk of ~1.5% (17.5% total).",Low,Uncertain,Pathogenic,0.27,Cancer;Genital and urinary,Complex/Other,Heterozygous,12384782;15368467;18767027;20231859,rs4792311,2,chr17,12915009,A,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Homozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
MPO-M251T,MPO,"A single sporadic observation implicated this variant in causing myeloperoxidase (MPO) deficiency in a recessive manner, but lacks any statistical significance. MPO deficiency generally causes no symptoms, but there are reports of associations with some cancers.",Low,Uncertain,Pathogenic,0.0091,Cancer;Metabolism,Recessive,Heterozygous,9354683,,5,chr17,56356502,G,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Homozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
WFS1-R611H,WFS1,"This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).",Low,Uncertain,Not Reviewed,0.4,Hearing and vision;Immune system;Metabolism,Recessive,Heterozygous,17603484;17719176;23257691,rs734312,1,chr4,6303354,A,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
rs1544410,,"rs1544410 is a Vitamin D Receptor (VDR) single nucleotide polymorphism. It is unlikely that it has functional significance because it is located in an intron (Liu et. al.), but it is in strong linkage disequilibrium with rs731236 (Dvornyk et al), which is located in an exon. ",Low,Uncertain,Pharmacogenetic,0.35,Other,Unknown,Heterozygous,,rs1544410,0,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
PCSK9-R46L,PCSK9,This variant is reported to have a dominant protective effect against coronary heart disease. Carriers of this variant have about half the risk of coronary heart disease compared to non-carriers (6.3% risk in carriers vs. 11.8% risk in non-carriers).,Moderate,Likely,Protective,0.01,Heart and circulatory,Unknown,Heterozygous,16554528,rs11591147,3,chr1,55505647,T,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
NPC1-H215R,NPC1,"This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6"" individual).





",Low,Likely,Protective,0.3,Metabolism,Complex/Other,Heterozygous,19151714;19174833;19910939,rs1805081,2,chr18,21140432,C,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
TOR1A-D216H,TOR1A,This SNP has been shown to be benign and play a protective role against Dystonia.  ,Low,Likely,Protective,0.1,Nervous system,Unknown,Heterozygous,18519876;19380705;20669276,rs1801968,1,chr9,132580901,G,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Heterozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
MTR-D919G,MTR,"This variant was weakly associated with a protective effect vs. colorectal cancer, but only in individuals with low alcohol consumption.


",Low,Uncertain,Protective,0.22,Cancer,Complex/Other,Heterozygous,10498402;14744749;17417062;17855192,rs1805087,1,chr1,237048500,G,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
IRS2-G1057D,IRS2,"a.k.a Gly1057Asp, insulin receptor substrate-2 IRS2. The rs1805097(G) allele is associated with the Gly, and the (A) allele with Asp. 
A longevity study concluded that rs1805097(A;A) individuals were about twice as likely to live over 85 y/o (odds ratio 2.03, CI:1.39-2.99, p = .0003). ",Low,Uncertain,Protective,0.23,Other,Unknown,Heterozygous,19887537,rs1805097,,chr13,110435231,T,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
DMD-R2155W,DMD,Probably benign.,Low,Likely,Benign,0.027,Other,Unknown,Heterozygous,9298822,rs1800273,,chrX,31986607,A,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
PMS2-P470S,PMS2,"Benign, common variant.",Low,Likely,Benign,0.37,Other,Unknown,Heterozygous,15256438,rs1805321,,chr7,6026988,A,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
COL9A2-T246M,COL9A2,Probably benign.,Low,Likely,Benign,0.025,Other,Unknown,Heterozygous,11565064,rs2228565,,chr1,40775937,A,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
FANCA-M717I,FANCA,"Rare polymorphism, not considered pathogenic.",Low,Likely,Benign,0.022,Other,Unknown,Heterozygous,10521298,rs1131660,,chr16,89838086,A,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
CACNA1S-L458H,CACNA1S,Common polymorphism,Low,Likely,Benign,0.27,Other,Unknown,Heterozygous,,rs12742169,,chr1,201052310,T,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
MLH1-I219V,MLH1,"Computational evidence, functional assays, and case/control studies suggest this variant is probably benign.",Low,Uncertain,Benign,0.24,Other,Dominant,Heterozygous,11781295;12810663;17074586;17510385;17870204;19863800;20301390;22631669,rs1799977,0,chr3,37053568,G,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
GAA-E689K,GAA,This is also known as the GAA*4 allozyme is frequent in the Asian population and appears to have somewhat reduced enzyme activity. Kroos et al. rule out pathogenic effect.,Low,Uncertain,Benign,0.03,Other,Complex/Other,Heterozygous,18301443,rs1800309,,chr17,78087041,A,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
TYR-S192Y,TYR,This variant is reported to affect skin pigmentation. It is associated with lighter skin in South Asians (OR 4-5) and with a lack of freckles in Europeans (OR 1.3).,Low,Uncertain,Benign,0.27,Skin,Unknown,Homozygous,17952075;17999355,rs1042602,,chr11,88911696,A,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
GALT-N314D,GALT,"This variant has an allele frequency of ~8% and is ancestral to ""Duarte"" / ""Duarte 2"" and ""Duarte 1""/""Los Angeles"" galactosemia variants. This variant is evolutionarily ancestral, and in vitro studies fail to support an impact of this variant on enzyme activity. Carney et al. instead implicate a 4 base deletion on the 5' of the GALT gene as being causal and linked to this variant. Galactosemia is typically screened and detected in infants and causes early, severe but nonspecific symptoms (digestive problems, lethargy, failure to thrive).",Low,Uncertain,Benign,0.072,"Mouth, liver, and digestive",Unknown,Heterozygous,10408771;11261429;19224951,rs2070074,,chr9,34649442,G,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
MAPT-Q230R,MAPT,Common polymorphism.,Low,Uncertain,Benign,0.042,Other,Unknown,Heterozygous,15365985,rs63750072,,chr17,44060859,G,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
PTCH1-P1315L,PTCH1,"Common polymorphism, presumed benign.",Low,Uncertain,Benign,0.3,Other,Unknown,Heterozygous,15712338,rs357564,,chr9,98209594,A,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
PKP2-L366P,PKP2,This variant is a benign polymorphism.  ,Low,Uncertain,Benign,0.22,Other,Unknown,Heterozygous,19955750,rs1046116,,chr12,33021934,G,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
AMPD1-P48L,AMPD1,"Probably benign, ancestral to15173240 pathogenic Q12X mutation.",Low,Uncertain,Benign,0.094,Other,Unknown,Heterozygous,15173240,rs61752479,,chr1,115231254,A,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
RP1-N985Y,RP1,"Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.",Low,Uncertain,Benign,0.35,Metabolism,Unknown,Heterozygous,12764676;19364639,rs2293869,,chr8,55539395,T,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
TAS2R38-A49P,TAS2R38,"This variant is strongly associated with causing the ""taster"" phenotype of phenylthiocarbamine (PTC) in a dominant manner.",Low,Uncertain,Benign,0.43,Other,Unknown,Heterozygous,12595690;15883422;20675712,rs713598,,chr7,141673345,G,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
TAS2R38-I296V,TAS2R38,"This variant is associated with ""taster"" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.",Low,Uncertain,Benign,0.46,Other,Unknown,Heterozygous,12595690;20675712,rs10246939,,chr7,141672604,C,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
TPCN2-G734E,TPCN2,Pigmentation allele.,Low,Uncertain,Benign,0.29,Other,Unknown,Heterozygous,18488028,rs3829241,,chr11,68855363,A,http://evidence.pgp-hms.org/genomes?display_genome_id=119f1142513eccefccd54ddbbf7511d945845c90
